Dong-Gi Lee
Fortuna: 387 M $ al 31/05/2026
Fortuna: 387 M $ al 31/05/2026
Dong-Gi Lee is the founder of OliX Pharmaceuticals, Inc. since 2010, holding the title of Chief Executive Officer & Director since 2015.
Dr. Lee is currently the Chief Executive Officer of Olix Us, Inc. since 2015 and a Professor at Sungkyunkwan University since 2008.
Education includes a doctorate from Cornell University conferred in 1999 and an undergraduate degree from Korea Advanced Institute of Science & Technology.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
OLIX PHARMACEUTICALS, INC. 16,41 % | 01/06/2026 | 3.330.827 ( 16,41 % ) | 387 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| OLIX PHARMACEUTICALS, INC | Fundador | 01/02/2010 |
Olix Us, Inc. | Director Ejecutivo | 01/07/2015 |
Sungkyunkwan University
Sungkyunkwan University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/03/2008 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Korea Advanced Institute of Science & Technology
Korea Advanced Institute of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sungkyunkwan University
Sungkyunkwan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OliX Pharmaceuticals, Inc.
OliX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs against locally treatable diseases | Health Technology |
Olix Us, Inc. | Electronic Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.